XENiOS®, a commercial-stage medical device company, announced today it expects to receive CE-marking for its i-lung® device within 18 months. XENIOS expects to launch i-lung® in 2017. Currently available devices lack durability and wearability. Additionally, the size of current systems restricts patient mobility and limits quality of life.
Read more ...
Women Can Now Track Their Fertility with Apple Watch
Knowing when to get pregnant may be one of the most important pieces of personal health information. Yet, a recent study conducted on 3,000 men and women across the US, UK and Sweden, reveals that less than 30% are aware of how the female body works.(1) Natural Cycles, the clinically-tested fertility app, aims to change that and announced the launch of their Apple Watch app.
Read more ...
Wolters Kluwer Expands UpToDate with Primary Care Sports Medicine
The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that it has added primary care sports medicine to UpToDate®, its evidence-based clinical decision support resource, marking the 23rd medical specialty available to subscribing clinicians and healthcare institutions around the world.
Read more ...
Ascom Acquires the Italian Medical Software Company UMS
Ascom has acquired the Italian software company UMS (United Medical Software), which provides integrations for medical devices and supplies digital medical records software solutions for life-critical patient care. With the acquisition of UMS, Ascom will gain access to new software and competence for global integrated workflow solutions in Healthcare ICT.
Read more ...
Wolters Kluwer Health Announces Launch of UpToDate Anywhere in Italy
The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today the launch of UpToDate® Anywhere in Italy. UpToDate Anywhere enables hospitals and healthcare organizations to provide clinicians with mobile and EHR-based access to UpToDate, the acclaimed evidence-based clinical decision support resource.
Read more ...
Philips Completes Cancellation of 21,361,016 Million Shares
Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has completed the cancellation of 21,361,016 of its shares. The cancelled shares were acquired from November 1, 2014, up to and including November 20, 2015, as part of Philips' EUR 1.5 billion share repurchase program that started on October 21, 2013, and is executed over a three year period.
Read more ...
Novo Nordisk and IBM Partner to Build Diabetes Care Solutions on the Watson Health Cloud
Novo Nordisk and IBM (NYSE: IBM) Watson Health today announced that the two companies will work together to create diabetes solutions built on the Watson Health Cloud. The agreement combines Novo Nordisk's deep understanding of diabetes with IBM's leadership in cognitive computing.
Read more ...